374 related articles for article (PubMed ID: 33142228)
1. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Atukuri D; S V; R S; L V; R P; M M R
Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives.
Guan YF; Liu XJ; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Li W; Zhang SY
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443487
[TBL] [Abstract][Full Text] [Related]
3. N-Heterocyclic choline analogues based on 1,2,3,4-tetrahydro(iso)quinoline scaffold with anticancer and anti-infective dual action.
Zablotskaya A; Segal I; Geronikaki A; Shestakova I; Nikolajeva V; Makarenkova G
Pharmacol Rep; 2017 Jun; 69(3):575-581. PubMed ID: 28364698
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and molecular docking study of novel quinoline-based bis-chalcones as potential antitumor agents.
Insuasty D; García S; Abonia R; Insuasty B; Quiroga J; Nogueras M; Cobo J; Borosky GL; Laali KK
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100094. PubMed ID: 34050547
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
[TBL] [Abstract][Full Text] [Related]
6. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Active Heterocyclic Chalcones: Recent Developments.
Dandawate P; Ahmed K; Padhye S; Ahmad A; Biersack B
Anticancer Agents Med Chem; 2021; 21(5):558-566. PubMed ID: 32628595
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive review on the biological interest of quinoline and its derivatives.
Matada BS; Pattanashettar R; Yernale NG
Bioorg Med Chem; 2021 Feb; 32():115973. PubMed ID: 33444846
[TBL] [Abstract][Full Text] [Related]
9. Recent update on antibacterial and antifungal activity of quinoline scaffolds.
Dorababu A
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000232. PubMed ID: 33210348
[TBL] [Abstract][Full Text] [Related]
10. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
11. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
Mahapatra DK; Bharti SK; Asati V; Singh SK
Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
[TBL] [Abstract][Full Text] [Related]
12. Quinoline: An Attractive Scaffold in Drug Design.
Moor LFE; Vasconcelos TRA; da R Reis R; Pinto LSS; da Costa TM
Mini Rev Med Chem; 2021; 21(16):2209-2226. PubMed ID: 33568032
[TBL] [Abstract][Full Text] [Related]
13. Quinoline as a privileged scaffold in cancer drug discovery.
Solomon VR; Lee H
Curr Med Chem; 2011; 18(10):1488-508. PubMed ID: 21428893
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.
Li W; Xu F; Shuai W; Sun H; Yao H; Ma C; Xu S; Yao H; Zhu Z; Yang DH; Chen ZS; Xu J
J Med Chem; 2019 Jan; 62(2):993-1013. PubMed ID: 30525584
[TBL] [Abstract][Full Text] [Related]
15. Biological activities of quinoline derivatives.
Kumar S; Bawa S; Gupta H
Mini Rev Med Chem; 2009 Dec; 9(14):1648-54. PubMed ID: 20088783
[TBL] [Abstract][Full Text] [Related]
16. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives.
Dhaliwal JS; Moshawih S; Goh KW; Loy MJ; Hossain MS; Hermansyah A; Kotra V; Kifli N; Goh HP; Dhaliwal SKS; Yassin H; Ming LC
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296655
[TBL] [Abstract][Full Text] [Related]
18. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives.
Shaik A; Bhandare RR; Palleapati K; Nissankararao S; Kancharlapalli V; Shaik S
Molecules; 2020 Feb; 25(5):. PubMed ID: 32110945
[TBL] [Abstract][Full Text] [Related]
20. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
